Medical device developer Medtronic has submitted the first premarket approval application (PMA) module for its Endeavor drug-eluting coronary stent to the Food and Drug Administration.
The module is the first of four modules Medtronic will file with the FDA over the coming year, according to the Minneapolis-based firm. Endeavor received regulatory approval from the European Commission in July.
By AuntMinnie.com staff writers
October 10, 2005
Related Reading
Medtronic signs O-arm distribution deal, September 29, 2005
Medtronic launches Valiant thoracic stent, July 13, 2005
Medtronic, Cleveland Clinic launch PIVOTAL trial, July 7, 2005
Medtronic completes VALOR enrollment, June 17, 2005
Medtronic gets nod for multipurpose catheter, June 8, 2005
Copyright © 2005 AuntMinnie.com
